ABEONA THERAPEUTICS INC.

For the period ended Dec 31, 2025. Filed Mar 17, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 17, 2026

ABEO$2.54-39.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ABEONA THERAPEUTICS INC.
Date: March 17, 2026	By:	/s/ Vishwas Seshadri
		Vishwas Seshadri
		President and Chief Executive Officer
		(Principal Executive Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Date: March 17, 2026	/s/ Vishwas Seshadri
	Vishwas Seshadri
	President, Chief Executive Officer and Director
	(Principal Executive Officer)
Date: March 17, 2026	/s/ Joseph Vazzano
	Joseph Vazzano
	Chief Financial Officer
	(Principal Financial and Accounting Officer)
Date: March 17, 2026	/s/ Leila Alland
	Leila Alland, Director
Date: March 17, 2026	/s/ Mark J. Alvino
	Mark J. Alvino, Director
Date: March 17, 2026	/s/ Michael Amoroso
	Michael Amoroso, Director
	Chairman of the Board
Date: March 17, 2026	/s/ Faith L. Charles
	Faith L. Charles, Director
Date: March 17, 2026	/s/ Eric Crombez, MD
	Eric Crombez, MD, Director
Date: March 17, 2026	/s/ Christine Silverstein
	Christine Silverstein, Director
Date: March 17, 2026	/s/ Donald A. Wuchterl
	Donald A. Wuchterl, Director
Date: March 17, 2026	/s/ Bernhardt G. Zeiher, MD, FCCP, FACP
	Bernhardt G. Zeiher, MD, FCCP, FACP, Director

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.